Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods
Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects:...
Kjems, L. L.; Vølund, A.; Madsbad, S.
2001-10-01 00:00:00
The ISEC method can be applied to normal, obese or Type II diabetic patients. In patients with deviating kinetics of C-peptide the Eaton deconvolution method is the method of choice while the one-compartment combined model is suitable for measuring only the first-phase insulin secretion. (Diabetologia (2001) 44: 1339–1348)
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngDiabetologiaSpringer Journalshttp://www.deepdyve.com/lp/springer-journals/quantification-of-beta-cell-function-during-ivgtt-in-type-ii-and-non-MW0YjcNgja
Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods
The ISEC method can be applied to normal, obese or Type II diabetic patients. In patients with deviating kinetics of C-peptide the Eaton deconvolution method is the method of choice while the one-compartment combined model is suitable for measuring only the first-phase insulin secretion. (Diabetologia (2001) 44: 1339–1348)
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.